|
Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial Clinical research trials and Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial. Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial clinical trial. Participants frequently get the best healthcare available for their Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "O" Clinical Trials Conditions > Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
For Condition: Major Depressive Disorder
Status: Recruiting
Sponsor(s): Eli Lilly and Company ,
Synopsis: The primary objective of this study is to provide duloxetine to investigators for the treatment of patients who have previously participated in neuroscience duloxetine clinical trials and for whom effective alternative therapy is not available.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Male and Female outpatients at least 18 years of age who have previously particpated in a Lilly sponsored neuroscience duloxetine clinical trial - All females must have a negative urine pregnancy test at visit 1. Females of chilbearing potential must agree to utilize medically acceptable and reliable means of birth control. - Must sign the informed consent document Exclusion Criteria: - Have received treatment within the last 30 days with a drug except for duloxetine that has not received regulatory approval for any indication at the time of study entry - In the opinion of the investigator, patient judged to be at serious suicidal risk. - Serious or unstable hepatic or renal function or unstable narrow angle glaucoma. - Treatment with a monoamine oxidase inhibitor (MAOI) within 14 days prior to visit 1 or potential to use a MAOI during the study or within 5 days of discontinuation of study drug. - Any patient who previously experienced a serious adverse event while taking duloxetine unless approved by the Lilly Physician
Total Enrollment:
Location and Contact Information:
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
San Antonio, Texas,
United States
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Dallas, Texas,
United States
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Lasi, ,
Romania
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Beachwood, Ohio,
United States
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Nedlands, Western Australia,
Australia
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Oklahoma City, Oklahoma,
United States
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Bucuresti, Sector 4, ,
Romania
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Wyomissing, Pennsylvania,
United States
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Fullerton, South Australia,
Australia
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Woodstock, Vermont,
United States
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Roma, ,
Italy
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Ponce, ,
Puerto Rico
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Changhua, Taiwan,
Taiwan, Province of China
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Hamden, Connecticut,
United States
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Timisoara, ,
Romania
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Media, Pennsylvania,
United States
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Quebec City, Quebec,
Canada
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Richmond, Virginia,
United States
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Ottawa, Ontario,
Canada
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) with your personal physician. *Recruiting*
Cincinnati, Ohio,
United States
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Baltimore, Maryland,
United States
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Courtice, Ontario,
Canada
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Sherbrooke, Quebec,
Canada
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Belmont, Massachusetts,
United States
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Box Hill, Victoria,
Australia
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
West Allis, Wisconsin,
United States
Recruiting
Additional Information:
Study ID Numbers: 7443;
Study Start Date:
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00071708
Other Major Depressive Disorder Studies:
1. Treatment of Depression in Nursing Homes
2. Treatment of Patients with Major Depressive Disorder with an Investigational Compound
3. Adult Outpatients with Major Depressive Disorder
4. Treatment Resistant Depression Study
5. Treatment of Patients with Major Depressive Disorder with an Investigational Compound
Related Studies:
Other Major Depressive Disorder Clinical Trials
Other Clinical Trials
Other Lasi Clinical Trials
Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
|
|
|
|
|
|
|
|